Claims for Patent: 6,649,187
✉ Email this page to a colleague
Summary for Patent: 6,649,187
| Title: | Use of polyalkylamine polymers in controlled release devices |
| Abstract: | The invention provides a method and device for administering an amine drug, such as [S-(R,S)]-2-[4-[[(4-methyl)piperazin-1-yl]carbonyl]phenoxy]-3,3-diethyl-N-[1-(3,4-methylenedioxyphenyl)butyl]-4-oxo-1-azetidinecarboxamide), in a sustained release dosage form. The invention includes a pharmaceutical composition and dosage form containing a polyalkylamine polymer and an amine drug. The polyalkylamine polymer is a hydrogel that forms hydrated particles when exposed to an aqueous environment. When mixed with the amine drug in the core of a coated tablet, the polyalkylamine polymer controls the release of the amine drug into an aqueous environment of use. The hydrated particles of the polymer together with the amine drug are released from the tablet core through plural apertures in the surrounding coat. |
| Inventor(s): | Munir A. Hussain, Arnold J. Repta |
| Assignee: | Bristol Myers Squibb Pharma Co |
| Application Number: | US10/074,385 |
Details for Patent 6,649,187
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Zenpep, Llc | ZENPEP | pancrelipase | Capsule, Delayed Release | 022210 | August 27, 2009 | 6,649,187 | 2022-02-12 |
| Zenpep, Llc | ZENPEP | pancrelipase | Capsule, Delayed Release | 022210 | June 15, 2011 | 6,649,187 | 2022-02-12 |
| Zenpep, Llc | ZENPEP | pancrelipase | Capsule, Delayed Release | 022210 | July 13, 2011 | 6,649,187 | 2022-02-12 |
| Zenpep, Llc | ZENPEP | pancrelipase | Capsule, Delayed Release | 022210 | March 25, 2014 | 6,649,187 | 2022-02-12 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
